Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure (NCT00762008)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this research is to determine if two proteins in the blood are increased during acute heart failure. These two proteins are produced when the heart becomes dysfunctional and unable to contract normally. They may then be released into the blood and be detected by standard method in the research laboratory. Thus, the purpose of this study is to determine the relation between the change of these two proteins in the blood and the occurrence of acute heart failure. At this time, detection of an increase in these proteins in the blood is not known to be associated with any disease or heart failure.
Who can join: Review the eligibility criteria below.
Location: University of Connecticut Health Center — Farmington, Connecticut
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Connecticut Health Center — Farmington, Connecticut
📞 Contact the Study Coordinator
Phone: (860) 679-7549
Email: siedlarz@uchc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Acute Decompensated Heart Failure
- IC14 for Treatment of Acute Decompensated Heart Failure — Charlottesville, Virginia
- A Study Of Acute Decompensated Heart Failure — Rochester, Minnesota
- Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) — Irvine, California
- Low Level Tragus Stimulation in Acute Decompensated Heart Failure — Oklahoma City, Oklahoma
Explore by condition: All Acute Decompensated Heart Failure clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.